The latest quarterly R&D expense is $202.00 Million with a QoQ Growth of +23.17%. Research and Development (R&D) expenses represent the costs incurred by a company in developing new products, services, or processes.
Q2 FY2026 (2026-06-30).
Reported quarterly R&D expense; no daily interpolation. Q2 FY2026 (2026-06-30): $202.00M.
$202.00M
$202.00 Million
Q2 FY2026 · 2026-06-30
+23.17%
vs. $164.00M prior quarter
22
Quarters of data available
| Period | R&D Expense | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2026Period end 2026-06-30 | $202.00M | +23.17% | +21.69% |
| Q1 FY2026Period end 2026-03-31 | $164.00M | -4.09% | +13.89% |
| Q4 FY2025Period end 2025-12-31 | $171.00M | +1.18% | +10.32% |
| Q3 FY2025Period end 2025-09-30 | $169.00M | +1.81% | +13.42% |
| Q2 FY2025Period end 2025-06-30 | $166.00M | +15.28% | -10.27% |
| Q1 FY2025Period end 2025-03-31 | $144.00M | -7.10% | +25.22% |
| Q4 FY2024Period end 2024-12-31 | $155.00M | +4.03% | -24.39% |
| Q3 FY2024Period end 2024-09-30 | $149.00M | -19.46% | -91.95% |
| Q2 FY2024Period end 2024-06-30 | $185.00M | +60.87% | +42.31% |
| Q1 FY2024Period end 2024-03-31 | $115.00M | -43.90% | -9.45% |
| Q4 FY2023Period end 2023-12-31 | $205.00M | -88.92% | +38.51% |
| Q3 FY2023Period end 2023-09-30 | $1.85B | +1323.08% | +1356.69% |
| Q2 FY2023Period end 2023-06-30 | $130.00M | +2.36% | +0.78% |
| Q1 FY2023Period end 2023-03-31 | $127.00M | -14.19% | +11.40% |
| Q4 FY2022Period end 2022-12-31 | $148.00M | +16.54% | +36.41% |
| Q3 FY2022Period end 2022-09-30 | $127.00M | -1.55% | +17.05% |
| Q2 FY2022Period end 2022-06-30 | $129.00M | +13.16% | +48.28% |
| Q1 FY2022Period end 2022-03-31 | $114.00M | +5.07% | +50.99% |
| Q4 FY2021Period end 2021-12-31 | $108.50M | 0.00% | N/A |
| Q3 FY2021Period end 2021-09-30 | $108.50M | +24.71% | N/A |
| Q2 FY2021Period end 2021-06-30 | $87.00M | +15.23% | N/A |
| Q1 FY2021Period end 2021-03-31 | $75.50M | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.
